$278 Million is the total value of ARMISTICE CAPITAL, LLC's 28 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 92.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TRput | $30,884,000 | -0.3% | 150,000 | 0.0% | 11.09% | -19.2% | |
| SPPI | Buy | SPECTRUM PHARMACEUTICALS INC | $30,342,000 | +85.1% | 4,436,000 | +64.3% | 10.90% | +50.0% |
| APOL | Buy | APOLLO ED GROUP INCcl a | $16,358,000 | +116.1% | 1,270,000 | +217.5% | 5.88% | +75.2% |
| KODK | Buy | EASTMAN KODAK CO | $16,128,000 | +41.5% | 960,000 | +60.0% | 5.79% | +14.7% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $14,492,000 | -31.8% | 1,142,000 | -50.0% | 5.20% | -44.7% |
| ATRS | Buy | ANTARES PHARMA INC | $13,312,000 | +29.3% | 6,400,000 | +68.4% | 4.78% | +4.8% |
| RXDX | Sell | IGNYTA INC | $13,128,000 | -25.9% | 870,000 | -51.1% | 4.72% | -39.9% |
| FTDCQ | New | FTD COS INC | $12,911,000 | – | 458,000 | +100.0% | 4.64% | – |
| TBPH | Buy | THERAVANCE BIOPHARMA INC | $12,681,000 | +42.8% | 974,000 | +90.2% | 4.56% | +15.7% |
| QLGC | Buy | QLOGIC CORP | $11,522,000 | +67.0% | 812,000 | +73.5% | 4.14% | +35.4% |
| BCOR | Sell | BLUCORA INC | $11,305,000 | +6.9% | 700,000 | -9.6% | 4.06% | -13.3% |
| SKUL | New | SKULLCANDY INC | $10,784,000 | – | 1,406,000 | +100.0% | 3.87% | – |
| OSTK | Buy | OVERSTOCK COM INC DEL | $10,053,000 | +484.5% | 446,000 | +528.2% | 3.61% | +373.9% |
| XNPT | New | XENOPORT INC | $9,808,000 | – | 1,600,000 | +100.0% | 3.52% | – |
| ANF | New | ABERCROMBIE & FITCH COcl a | $8,862,000 | – | 412,000 | +100.0% | 3.18% | – |
| HWAY | New | HEALTHWAYS INC | $7,667,000 | – | 640,000 | +100.0% | 2.75% | – |
| LPCN | New | LIPOCINE INC NEW | $7,293,000 | – | 850,000 | +100.0% | 2.62% | – |
| SNAK | Buy | INVENTURE FOODS INC | $6,273,000 | -6.6% | 618,000 | +3.0% | 2.25% | -24.3% |
| ACOR | New | ACORDA THERAPEUTICS INC | $6,199,000 | – | 186,000 | +100.0% | 2.23% | – |
| DMD | Buy | DEMAND MEDIA INC | $6,156,000 | +17.5% | 968,000 | +5.7% | 2.21% | -4.8% |
| STKL | New | SUNOPTA INC | $4,550,000 | – | 424,000 | +100.0% | 1.63% | – |
| JCPNQ | New | PENNEY J C INC | $4,235,000 | – | 500,000 | +100.0% | 1.52% | – |
| BITI | New | BIOTIE THERAPIES OYJsponsored adr | $3,994,000 | – | 200,000 | +100.0% | 1.44% | – |
| BDSI | New | BIODELIVERY SCIENCES INTL IN | $3,184,000 | – | 400,000 | +100.0% | 1.14% | – |
| QLTI | New | QLT INC | $2,726,000 | – | 660,000 | +100.0% | 0.98% | – |
| NSPR | Sell | INSPIREMD INC | $1,837,000 | -18.0% | 6,560,000 | -6.3% | 0.66% | -33.5% |
| FHCO | Sell | FEMALE HEALTH CO | $1,080,000 | -66.1% | 600,000 | -46.7% | 0.39% | -72.5% |
| RLOC | New | REACHLOCAL INC | $636,000 | – | 202,000 | +100.0% | 0.23% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -202,634 | -100.0% | -0.45% | – |
| IRGTQ | Exit | IGNITE RESTAURANT GROUP INC | $0 | – | -240,000 | -100.0% | -0.52% | – |
| IMUC | Exit | IMMUNOCELLULAR THERAPEUTICS | $0 | – | -2,471,500 | -100.0% | -0.53% | – |
| RPTP | Exit | RAPTOR PHARMACEUTICAL CORP | $0 | – | -130,000 | -100.0% | -0.63% | – |
| LL | Exit | LUMBER LIQUIDATORS HLDGS INC | $0 | – | -180,000 | -100.0% | -2.46% | – |
| IAC | Exit | IAC INTERACTIVECORP | $0 | – | -90,000 | -100.0% | -2.69% | – |
| SNTA | Exit | SYNTA PHARMACEUTICALS CORP | $0 | – | -3,240,000 | -100.0% | -2.79% | – |
| PGNX | Exit | PROGENICS PHARMACEUTICALS IN | $0 | – | -1,148,000 | -100.0% | -3.04% | – |
| KZ | Exit | KONGZHONG CORPsponsored adr | $0 | – | -1,250,000 | -100.0% | -3.06% | – |
| WIFI | Exit | BOINGO WIRELESS INC | $0 | – | -1,150,000 | -100.0% | -3.84% | – |
| VCRA | Exit | VOCERA COMMUNICATIONS INC | $0 | – | -906,000 | -100.0% | -3.98% | – |
| PBY | Exit | PEP BOYS MANNY MOE & JACK | $0 | – | -1,090,000 | -100.0% | -4.65% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.